An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx

By Oesterling J.E.   Moyad M.A.   Wright G.L.   Beck G.R.  

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 524-532

Elsevier

Access to resources Recommend Favorite

The appropriate lower limit for the percent free prostate-specific antigen reflex range - assay of the complex improves clinical sensitivity for cancer

By Carlson G.D.   Calvanese C.B.   Childs S.J.  

Urology, Vol. 52, Iss. 3, 1998-09 ,pp. : 450-454

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite

Enzyme-linked immunosorbent assay detection of prostate-specific antigen messenger ribonucleic acid in prostate cancer - an archival tissue study

By Hoshi S.   Kobayashi S.   Takahashi T.   Suzuki K.-I.   Kawamura S.   Satoh M.   Chiba Y.   Orikasa S.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 228-235

Elsevier

Access to resources Recommend Favorite

Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay

By Ellis W.J.   Vessella R.L.   Noteboom J.L.   Lange P.H.   Wolfert R.L.   Rittenhouse H.G.  

Urology, Vol. 50, Iss. 4, 1997-10 ,pp. : 573-579

Elsevier

Access to resources Recommend Favorite